Anemia in Pregnancy: Rabika Fatima Rabia Saleem Almina Rehman
Anemia in Pregnancy: Rabika Fatima Rabia Saleem Almina Rehman
Anemia in Pregnancy: Rabika Fatima Rabia Saleem Almina Rehman
Rabika Fatima
Rabia Saleem
Almina Rehman
WHAT IS
ANEMIA?
• Maternal
• α - Thalassemia major can cause fetal hydrops and preecelampsia
• β - Thalassemia major females who survive childhood are usually sterile
• Fetal
• α - Thalassemia major can cause fetal hydrops; polyhydramnios, preterm
delivery, stillbirth
• β - Thalassemia major results in severe anemia, the child shows failure to thrive
and may die during childhood
MANAGEMENT
• Women should be seen antenatally to receive information about affects sickle cell
and how to improve outcomes.
• They should also be encouraged to have the hemoglobinopathies status of their
partners determined
• They should avoid precipitating factors of sickle cell crisis such as exposure to
extreme temperature, dehydration and over-exertion.
• Invasive testing can be done to detect the status of the fetus if both parents are
carriers
SICKLE CELL TRAIT
• Common in 5% pregnancy
• Characterized by macrocytic, hyper segmented neutrophils
• Risk factors
• Poor nutritional status
• Hemolytic anemias
• Hemoglobinopathies
• Drugs (Anti-epileptics, antibiotics, anti-cancer)
DIAGNOSIS
• Increase in:
• MCV>100 µm³
• MCHC (mean corpuscular hemoglobin concentration)
• Plasma homocysteine
• Decrease in:
• Serum folate levels
• RBC folate level
MANAGEMENT
• Management:
• Folic acid 1-3mg/d orally
• Iron supplementation
• weekly measurement of reticulocyte count and hematocrit
• Folic acid is given preconception and in early pregnancy
to reduce risk of Neural tube defects
• Dosage increased in women with high risk of NTDs:
• Patients on anti-convulsants
• Previous child with NTDs
• Hematological disorders
EFFECTS OF
ANEMIA ON
THE MOTHER